Shopping Cart
Remove All
Your shopping cart is currently empty
PMX 205 Trifluoroacetate is a potent complement antagonist of C5a receptor.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | $113 | Inquiry | Inquiry | |
| 5 mg | $296 | Inquiry | Inquiry |
| Description | PMX 205 Trifluoroacetate is a potent complement antagonist of C5a receptor. |
| In vitro | PMX205, which is an antagonist, gave more effects towards the cell as compared with the treatment of EP54. |
| In vivo | oral delivery of a cyclic hexapeptide C5a receptor antagonist (PMX205) for 2-3 mo resulted in substantial reduction of pathological markers such as fibrillar amyloid deposits (49-62%) and activated glia (42-68%) in two mouse models of AD. The reduction in pathology was correlated with improvements in a passive avoidance behavioral task in Tg2576 mice. In 3xTg mice, PMX205 also significantly reduced hyperphosphorylated tau (69%). These data provide the first evidence that inhibition of a proinflammatory receptor-mediated function of the complement cascade (i.e., C5aR) can interfere with neuroinflammation and neurodegeneration in AD rodent models, suggesting a novel therapeutic target for reducing pathology and improving cognitive function in human AD patients[3]. |
| Synonyms | PMX 205 Trifluoroacetate |
| Molecular Weight | 953.06 |
| Formula | C47H63F3N10O8 |
| Smiles | OC(C(F)(F)F)=O.O=C([C@H](NC([C@@]1([H])N(CCC1)C([C@](NC(CCC2=CC=CC=C2)=O)([H])CCCNC([C@H](CCCNC(N)=N)NC3=O)=O)=O)=O)CC4CCCCC4)N[C@@]3([H])CC5=CNC6=CC=CC=C56 |
| Relative Density. | no data available |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Solubility Information | DMSO: 100 mg/mL (104.93 mM), Sonication is recommended. H2O: 0.67 mg/mL (0.7 mM), Sonication is recommended. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.